Opioids Market by Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone and Others) and Application (Pain Management, Cough Treatment, and Diarrhea): Global Opportunity Analysis and Industry Forecast, 2019-2026
The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026. Opioids are drugs that stimulate the brain to produce a variety of effects, including pain relief. The term opioid refers to all substances (exogenous or endogenous) that possess morphine-like properties. Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.
The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Product Type
The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.
The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By Product Type
- Codeine
- Fentanyl
- Methadone
- Oxycodone
- Morphine
- Hydrocodone
- Pain Management
- Cough Treatment
- Diarrhea Treatment
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australis
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Purdue Pharma
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc.
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals Inc.
- Allergan, Plc
- Pfizer, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Cxo Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase Use of Opioids In Pain Management
3.4.1.2. Upsurge In Consumption of Opioids In Developing Economies
3.4.2. Restraints
3.4.2.1. Implementation of Stringent Government Regulation Toward Vigorous Prescription
3.4.2.2. Opioid Crisis Across The Globe
3.4.3. Impacting Factors
CHAPTER 4: OPIOIDS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market Size And Forecast, By Product Type
4.2. Codeine
4.2.1. Key Market Trends
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Fentanyl
4.3.1. Key Market Trends
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Oxycodone
4.4.1. Key Market Trends
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Methadone
4.5.1. Key Market Trends
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6. Morphine
4.6.1. Key Market Trends
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7. Hydrocodone
4.7.1. Key Market Trends
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8. Others
4.8.1. Key Market Trends
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
CHAPTER 5: OPIOIDS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size And Forecast, By Application
5.2. Pain Management
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.2.2.1. Neuropathic Pain
5.2.2.1.1. Market Size And Forecast
5.2.2.2. Migraine
5.2.2.2.1. Market Size And Forecast
5.2.2.3. Back Pain
5.2.2.3.1. Market Size And Forecast
5.2.2.4. Osteoarthritis Pain
5.2.2.4.1. Market Size And Forecast
5.2.2.5. Cancer Pain
5.2.2.5.1. Market Size And Forecast
5.2.2.6. Others
5.2.2.6.1. Market Size And Forecast
5.3. Cough Treatment
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Diarrhea Treatment
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
CHAPTER 6: OPIOIDS MARKET, BY REGION
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends
6.2.2. Market Size And Forecast, By Product
6.2.3. Market Size And Forecast, By Application
6.2.4. Market Size And Forecast, By Country
6.2.4.1. U.S. Market Size And Forecast, By Product
6.2.4.2. U.S. Market Size And Forecast, By Application
6.2.4.3. Canada Market Size And Forecast, By Product
6.2.4.4. Canada Market Size And Forecast, By Application
6.2.4.5. Mexico Market Size And Forecast, By Product
6.2.4.6. Mexico Market Size And Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends
6.3.2. Market Size And Forecast, By Product
6.3.3. Market Size And Forecast, By Application
6.3.4. Market Size And Forecast, By Country
6.3.4.1. France Market Size And Forecast, By Product
6.3.4.2. France Market Size And Forecast, By Application
6.3.4.3. Uk Market Size And Forecast, By Product
6.3.4.4. Uk Market Size And Forecast, By Application
6.3.4.5. Germany Market Size And Forecast, By Product
6.3.4.6. Germany Market Size And Forecast, By Application
6.3.4.7. Spain Market Size And Forecast, By Product
6.3.4.8. Spain Market Size And Forecast, By Application
6.3.4.9. Rest of Europe Market Size And Forecast, By Product
6.3.4.10. Rest of Europe Market Size And Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends
6.4.2. Market Size And Forecast, By Product
6.4.3. Market Size And Forecast, By Application
6.4.4. Market Size And Forecast, By Country
6.4.4.1. Japan Market Size And Forecast, By Product
6.4.4.2. Japan Market Size And Forecast, By Application
6.4.4.3. China Market Size And Forecast, By Product
6.4.4.4. China Market Size And Forecast, By Application
6.4.4.5. India Market Size And Forecast, By Product
6.4.4.6. India Market Size And Forecast, By Application
6.4.4.7. Australia Market Size And Forecast, By Product
6.4.4.8. Australia Market Size And Forecast, By Application
6.4.4.9. Taiwan Market Size And Forecast, By Product
6.4.4.10. Taiwan Market Size And Forecast, By Application
6.4.4.11. South Korea Market Size And Forecast, By Product
6.4.4.12. South Korea Market Size And Forecast, By Application
6.4.4.13. Rest of Asia-Pacific Market Size And Forecast, By Product
6.4.4.14. Rest of Asia-Pacific Market Size And Forecast, By Application
6.5. Lamea
6.5.1. Key Market Trends
6.5.2. Market Size And Forecast, By Product
6.5.3. Market Size And Forecast, By Application
6.5.4. Market Size And Forecast, By Country
6.5.4.1. Brazil Market Size And Forecast, By Product
6.5.4.2. Brazil Market Size And Forecast, By Application
6.5.4.3. Turkey Market Size And Forecast, By Product
6.5.4.4. Turkey Market Size And Forecast, By Application
6.5.4.5. Saudi Arabia Market Size And Forecast, By Product
6.5.4.6. Saudi Arabia Market Size And Forecast, By Application
6.5.4.7. South Africa Market Size And Forecast, By Product
6.5.4.8. South Africa Market Size And Forecast, By Application
6.5.4.9. Rest of Lamea Market Size And Forecast, By Product
6.5.4.10. Rest of Lamea Market Size And Forecast, By Application
CHAPTER 7: COMPONY PROFILES
7.1. Allergan Plc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Boehringer Ingelheim Group
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Johnson & Johnson (Janssen Global Services, Llc)
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Mallinckrodt Plc (Specgx Llc)
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Pfizer Inc.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Purdue Pharma L.P.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Sanofi S.A.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Sun Pharmaceutical Industries Ltd.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Teva Pharmaceutical Industries Limited
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Cxo Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase Use of Opioids In Pain Management
3.4.1.2. Upsurge In Consumption of Opioids In Developing Economies
3.4.2. Restraints
3.4.2.1. Implementation of Stringent Government Regulation Toward Vigorous Prescription
3.4.2.2. Opioid Crisis Across The Globe
3.4.3. Impacting Factors
CHAPTER 4: OPIOIDS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market Size And Forecast, By Product Type
4.2. Codeine
4.2.1. Key Market Trends
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Fentanyl
4.3.1. Key Market Trends
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Oxycodone
4.4.1. Key Market Trends
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Methadone
4.5.1. Key Market Trends
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6. Morphine
4.6.1. Key Market Trends
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7. Hydrocodone
4.7.1. Key Market Trends
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8. Others
4.8.1. Key Market Trends
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
CHAPTER 5: OPIOIDS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size And Forecast, By Application
5.2. Pain Management
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.2.2.1. Neuropathic Pain
5.2.2.1.1. Market Size And Forecast
5.2.2.2. Migraine
5.2.2.2.1. Market Size And Forecast
5.2.2.3. Back Pain
5.2.2.3.1. Market Size And Forecast
5.2.2.4. Osteoarthritis Pain
5.2.2.4.1. Market Size And Forecast
5.2.2.5. Cancer Pain
5.2.2.5.1. Market Size And Forecast
5.2.2.6. Others
5.2.2.6.1. Market Size And Forecast
5.3. Cough Treatment
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Diarrhea Treatment
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
CHAPTER 6: OPIOIDS MARKET, BY REGION
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends
6.2.2. Market Size And Forecast, By Product
6.2.3. Market Size And Forecast, By Application
6.2.4. Market Size And Forecast, By Country
6.2.4.1. U.S. Market Size And Forecast, By Product
6.2.4.2. U.S. Market Size And Forecast, By Application
6.2.4.3. Canada Market Size And Forecast, By Product
6.2.4.4. Canada Market Size And Forecast, By Application
6.2.4.5. Mexico Market Size And Forecast, By Product
6.2.4.6. Mexico Market Size And Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends
6.3.2. Market Size And Forecast, By Product
6.3.3. Market Size And Forecast, By Application
6.3.4. Market Size And Forecast, By Country
6.3.4.1. France Market Size And Forecast, By Product
6.3.4.2. France Market Size And Forecast, By Application
6.3.4.3. Uk Market Size And Forecast, By Product
6.3.4.4. Uk Market Size And Forecast, By Application
6.3.4.5. Germany Market Size And Forecast, By Product
6.3.4.6. Germany Market Size And Forecast, By Application
6.3.4.7. Spain Market Size And Forecast, By Product
6.3.4.8. Spain Market Size And Forecast, By Application
6.3.4.9. Rest of Europe Market Size And Forecast, By Product
6.3.4.10. Rest of Europe Market Size And Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends
6.4.2. Market Size And Forecast, By Product
6.4.3. Market Size And Forecast, By Application
6.4.4. Market Size And Forecast, By Country
6.4.4.1. Japan Market Size And Forecast, By Product
6.4.4.2. Japan Market Size And Forecast, By Application
6.4.4.3. China Market Size And Forecast, By Product
6.4.4.4. China Market Size And Forecast, By Application
6.4.4.5. India Market Size And Forecast, By Product
6.4.4.6. India Market Size And Forecast, By Application
6.4.4.7. Australia Market Size And Forecast, By Product
6.4.4.8. Australia Market Size And Forecast, By Application
6.4.4.9. Taiwan Market Size And Forecast, By Product
6.4.4.10. Taiwan Market Size And Forecast, By Application
6.4.4.11. South Korea Market Size And Forecast, By Product
6.4.4.12. South Korea Market Size And Forecast, By Application
6.4.4.13. Rest of Asia-Pacific Market Size And Forecast, By Product
6.4.4.14. Rest of Asia-Pacific Market Size And Forecast, By Application
6.5. Lamea
6.5.1. Key Market Trends
6.5.2. Market Size And Forecast, By Product
6.5.3. Market Size And Forecast, By Application
6.5.4. Market Size And Forecast, By Country
6.5.4.1. Brazil Market Size And Forecast, By Product
6.5.4.2. Brazil Market Size And Forecast, By Application
6.5.4.3. Turkey Market Size And Forecast, By Product
6.5.4.4. Turkey Market Size And Forecast, By Application
6.5.4.5. Saudi Arabia Market Size And Forecast, By Product
6.5.4.6. Saudi Arabia Market Size And Forecast, By Application
6.5.4.7. South Africa Market Size And Forecast, By Product
6.5.4.8. South Africa Market Size And Forecast, By Application
6.5.4.9. Rest of Lamea Market Size And Forecast, By Product
6.5.4.10. Rest of Lamea Market Size And Forecast, By Application
CHAPTER 7: COMPONY PROFILES
7.1. Allergan Plc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Boehringer Ingelheim Group
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Johnson & Johnson (Janssen Global Services, Llc)
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Mallinckrodt Plc (Specgx Llc)
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Pfizer Inc.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Purdue Pharma L.P.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Sanofi S.A.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Sun Pharmaceutical Industries Ltd.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Teva Pharmaceutical Industries Limited
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
LIST OF TABLES
Table 01. Global Opioids Market, By Product, 2018–2026 ($Million)
Table 02. Codeine Market, By Region, 2018–2026 ($Million)
Table 03. Codeine Market, By Country, 2018–2026 ($Million)
Table 04. Fentanyl Market By Region 2018–2026 ($Million)
Table 05. Fentanyl Market, By Country, 2018–2026 ($Million)
Table 06. Oxycodone Market, By Region, 2018–2026 ($Million)
Table 07. Oxycodone Market, By Country, 2018–2026 ($Million)
Table 08. Methadone Market, By Region, 2018–2026 ($Million)
Table 09. Methadone Market, By Country, 2018–2026 ($Million)
Table 10. Morphine Market By Region, 2018–2026 ($Million)
Table 11. Morphine Market By Country, 2018–2026 ($Million)
Table 12. Hydrocodone Market, By Region, 2018–2026 ($Million)
Table 13. Hydrocodone Market, By Country, 2018–2026 ($Million)
Table 14. Other Opioid Drugs Market By Region, 2018–2026 ($Million)
Table 15. Other Opioid Drugs Market, By Country, 2018–2026 ($Million)
Table 16. Global Opioids Market, By Application, 2018–2026 ($Million)
Table 17. Opioids Market For Pain Management, By Region, 2018–2026 ($Million)
Table 18. Opioids Market For Cough Treatment, By Region, 2018–2026 ($Million)
Table 19. Opioids Market For Diarrhea Treatment, By Region, 2018–2026 ($Million)
Table 20. Opioids Market, By Region, 2018–2026 ($Million)
Table 21. North America Opioids Market, By Product, 2018–2026 ($Million)
Table 22. North America Opioids Market, By Application, 2018–2026 ($Million)
Table 23. North America Opioids Market, By Country, 2018–2026 ($Million)
Table 24. U.S. Opioids Market, By Product, 2018–2026 ($Million)
Table 25. U.S. Opioids Market, By Application, 2018–2026 ($Million)
Table 26. Canada Opioids Market, By Product, 2018–2026 ($Million)
Table 27. Canada Opioids Market, By Application, 2018–2026 ($Million)
Table 28. Mexico Opioids Market, By Product, 2018–2026 ($Million)
Table 29. Mexico Opioids Market, By Application, 2018–2026 ($Million)
Table 30. Europe Opioids Market, By Product, 2018–2026 ($Million)
Table 31. Europe Opioids Market, By Application, 2018–2026 ($Million)
Table 32. Europe Opioids Market, By Country, 2018–2026 ($Million)
Table 33. France Opioids Market, By Product, 2018–2026 ($Million)
Table 34. France Opioids Market, By Application, 2018–2026 ($Million)
Table 35. Uk Opioids Market, By Product, 2018–2026 ($Million)
Table 36. Uk Opioids Market, By Application, 2018–2026 ($Million)
Table 37. Germany Opioids Market, By Product, 2018–2026 ($Million)
Table 38. Germany Opioids Market, By Application, 2018–2026 ($Million)
Table 39. Spain Opioids Market, By Product, 2018–2026 ($Million)
Table 40. Spain Opioids Market, By Application, 2018–2026 ($Million)
Table 41. Rest of Europe Opioids Market, By Product, 2018–2026 ($Million)
Table 42. Rest of Europe Opioids Market, By Application, 2018–2026 ($Million)
Table 43. Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)
Table 44. Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)
Table 45. Asia-Pacific Opioids Market, By Country, 2018–2026 ($Million)
Table 46. Japan Opioids Market, By Product, 2018–2026 ($Million)
Table 47. Japan Opioids Market, By Application, 2018–2026 ($Million)
Table 48. China Opioids Market, By Product, 2018–2026 ($Million)
Table 49. China Opioids Market, By Application, 2018–2026 ($Million)
Table 50. India Opioids Market, By Product, 2018–2026 ($Million)
Table 51. India Opioids Market, By Application, 2018–2026 ($Million)
Table 52. Australia Opioids Market, By Product, 2018–2026 ($Million)
Table 53. Australia Opioids Market, By Application, 2018–2026 ($Million)
Table 54. Taiwan Opioids Market, By Product, 2018–2026 ($Million)
Table 55. Taiwan Opioids Market, By Application, 2018–2026 ($Million)
Table 56. South Korea Opioids Market, By Product, 2018–2026 ($Million)
Table 57. South Korea Opioids Market, By Application, 2018–2026 ($Million)
Table 58. Rest of Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)
Table 59. Rest of Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)
Table 60. Lamea Opioids Market, By Product, 2018–2026 ($Million)
Table 61. Lamea Opioids Market, By Application, 2018–2026 ($Million)
Table 62. Lamea Opioids Market, By Country, 2018–2026 ($Million)
Table 63. Brazil Opioids Market, By Product, 2018–2026 ($Million)
Table 64. Brazil Opioids Market, By Application, 2018–2026 ($Million)
Table 65. Turkey Opioids Market, By Product, 2018–2026 ($Million)
Table 66. Turkey Opioids Market, By Application, 2018–2026 ($Million)
Table 67. Saudi Arabia Opioids Market, By Product, 2018–2026 ($Million)
Table 68. Saudi Arabia Opioids Market, By Application, 2018–2026 ($Million)
Table 69. South Africa Opioids Market, By Product, 2018–2026 ($Million)
Table 70. South Africa Opioids Market, By Application, 2018–2026 ($Million)
Table 71. Rest of Lamea Opioids Market, By Product, 2018–2026 ($Million)
Table 72. Rest of Lamea Opioids Market, By Application, 2018–2026 ($Million)
Table 73. Allergan: Company Snapshot
Table 74. Allergan: Operating Segments
Table 75. Allergan: Product Portfolio
Table 76. Boehringer Ingelheim: Company Snapshot
Table 77. Boehringer Ingelheim: Operating Segments
Table 78. Boehringer Ingelheim: Product Portfolio
Table 79. Endo: Company Snapshot
Table 80. Endo: Operating Segments
Table 81. Endo: Product Portfolio
Table 82. J&J: Company Snapshot
Table 83. J&J: Operating Segments
Table 84. J&J: Product Type Portfolio
Table 85. Mallinckrodt: Company Snapshot
Table 86. Mallinckrodt: Operating Segments
Table 87. Mallinckrodt: Product Portfolio
Table 88. Pfizer: Company Snapshot
Table 89. Pfizer: Operating Segments
Table 90. Pfizer: Product Portfolio
Table 91. Purdue: Company Snapshot
Table 92. Purdue: Product Portfolio
Table 93. Sanofi: Company Snapshot
Table 94. Sanofi: Operating Segments
Table 95. Sanofi: Product Portfolio
Table 96. Sun Pharma: Company Snapshot
Table 97. Sun Pharma: Operating Segments
Table 98. Sun Pharma: Product Portfolio
Table 99. Teva: Company Snapshot
Table 100. Teva: Operating Segments
Table 101. Teva: Product Portfolio
Table 01. Global Opioids Market, By Product, 2018–2026 ($Million)
Table 02. Codeine Market, By Region, 2018–2026 ($Million)
Table 03. Codeine Market, By Country, 2018–2026 ($Million)
Table 04. Fentanyl Market By Region 2018–2026 ($Million)
Table 05. Fentanyl Market, By Country, 2018–2026 ($Million)
Table 06. Oxycodone Market, By Region, 2018–2026 ($Million)
Table 07. Oxycodone Market, By Country, 2018–2026 ($Million)
Table 08. Methadone Market, By Region, 2018–2026 ($Million)
Table 09. Methadone Market, By Country, 2018–2026 ($Million)
Table 10. Morphine Market By Region, 2018–2026 ($Million)
Table 11. Morphine Market By Country, 2018–2026 ($Million)
Table 12. Hydrocodone Market, By Region, 2018–2026 ($Million)
Table 13. Hydrocodone Market, By Country, 2018–2026 ($Million)
Table 14. Other Opioid Drugs Market By Region, 2018–2026 ($Million)
Table 15. Other Opioid Drugs Market, By Country, 2018–2026 ($Million)
Table 16. Global Opioids Market, By Application, 2018–2026 ($Million)
Table 17. Opioids Market For Pain Management, By Region, 2018–2026 ($Million)
Table 18. Opioids Market For Cough Treatment, By Region, 2018–2026 ($Million)
Table 19. Opioids Market For Diarrhea Treatment, By Region, 2018–2026 ($Million)
Table 20. Opioids Market, By Region, 2018–2026 ($Million)
Table 21. North America Opioids Market, By Product, 2018–2026 ($Million)
Table 22. North America Opioids Market, By Application, 2018–2026 ($Million)
Table 23. North America Opioids Market, By Country, 2018–2026 ($Million)
Table 24. U.S. Opioids Market, By Product, 2018–2026 ($Million)
Table 25. U.S. Opioids Market, By Application, 2018–2026 ($Million)
Table 26. Canada Opioids Market, By Product, 2018–2026 ($Million)
Table 27. Canada Opioids Market, By Application, 2018–2026 ($Million)
Table 28. Mexico Opioids Market, By Product, 2018–2026 ($Million)
Table 29. Mexico Opioids Market, By Application, 2018–2026 ($Million)
Table 30. Europe Opioids Market, By Product, 2018–2026 ($Million)
Table 31. Europe Opioids Market, By Application, 2018–2026 ($Million)
Table 32. Europe Opioids Market, By Country, 2018–2026 ($Million)
Table 33. France Opioids Market, By Product, 2018–2026 ($Million)
Table 34. France Opioids Market, By Application, 2018–2026 ($Million)
Table 35. Uk Opioids Market, By Product, 2018–2026 ($Million)
Table 36. Uk Opioids Market, By Application, 2018–2026 ($Million)
Table 37. Germany Opioids Market, By Product, 2018–2026 ($Million)
Table 38. Germany Opioids Market, By Application, 2018–2026 ($Million)
Table 39. Spain Opioids Market, By Product, 2018–2026 ($Million)
Table 40. Spain Opioids Market, By Application, 2018–2026 ($Million)
Table 41. Rest of Europe Opioids Market, By Product, 2018–2026 ($Million)
Table 42. Rest of Europe Opioids Market, By Application, 2018–2026 ($Million)
Table 43. Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)
Table 44. Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)
Table 45. Asia-Pacific Opioids Market, By Country, 2018–2026 ($Million)
Table 46. Japan Opioids Market, By Product, 2018–2026 ($Million)
Table 47. Japan Opioids Market, By Application, 2018–2026 ($Million)
Table 48. China Opioids Market, By Product, 2018–2026 ($Million)
Table 49. China Opioids Market, By Application, 2018–2026 ($Million)
Table 50. India Opioids Market, By Product, 2018–2026 ($Million)
Table 51. India Opioids Market, By Application, 2018–2026 ($Million)
Table 52. Australia Opioids Market, By Product, 2018–2026 ($Million)
Table 53. Australia Opioids Market, By Application, 2018–2026 ($Million)
Table 54. Taiwan Opioids Market, By Product, 2018–2026 ($Million)
Table 55. Taiwan Opioids Market, By Application, 2018–2026 ($Million)
Table 56. South Korea Opioids Market, By Product, 2018–2026 ($Million)
Table 57. South Korea Opioids Market, By Application, 2018–2026 ($Million)
Table 58. Rest of Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)
Table 59. Rest of Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)
Table 60. Lamea Opioids Market, By Product, 2018–2026 ($Million)
Table 61. Lamea Opioids Market, By Application, 2018–2026 ($Million)
Table 62. Lamea Opioids Market, By Country, 2018–2026 ($Million)
Table 63. Brazil Opioids Market, By Product, 2018–2026 ($Million)
Table 64. Brazil Opioids Market, By Application, 2018–2026 ($Million)
Table 65. Turkey Opioids Market, By Product, 2018–2026 ($Million)
Table 66. Turkey Opioids Market, By Application, 2018–2026 ($Million)
Table 67. Saudi Arabia Opioids Market, By Product, 2018–2026 ($Million)
Table 68. Saudi Arabia Opioids Market, By Application, 2018–2026 ($Million)
Table 69. South Africa Opioids Market, By Product, 2018–2026 ($Million)
Table 70. South Africa Opioids Market, By Application, 2018–2026 ($Million)
Table 71. Rest of Lamea Opioids Market, By Product, 2018–2026 ($Million)
Table 72. Rest of Lamea Opioids Market, By Application, 2018–2026 ($Million)
Table 73. Allergan: Company Snapshot
Table 74. Allergan: Operating Segments
Table 75. Allergan: Product Portfolio
Table 76. Boehringer Ingelheim: Company Snapshot
Table 77. Boehringer Ingelheim: Operating Segments
Table 78. Boehringer Ingelheim: Product Portfolio
Table 79. Endo: Company Snapshot
Table 80. Endo: Operating Segments
Table 81. Endo: Product Portfolio
Table 82. J&J: Company Snapshot
Table 83. J&J: Operating Segments
Table 84. J&J: Product Type Portfolio
Table 85. Mallinckrodt: Company Snapshot
Table 86. Mallinckrodt: Operating Segments
Table 87. Mallinckrodt: Product Portfolio
Table 88. Pfizer: Company Snapshot
Table 89. Pfizer: Operating Segments
Table 90. Pfizer: Product Portfolio
Table 91. Purdue: Company Snapshot
Table 92. Purdue: Product Portfolio
Table 93. Sanofi: Company Snapshot
Table 94. Sanofi: Operating Segments
Table 95. Sanofi: Product Portfolio
Table 96. Sun Pharma: Company Snapshot
Table 97. Sun Pharma: Operating Segments
Table 98. Sun Pharma: Product Portfolio
Table 99. Teva: Company Snapshot
Table 100. Teva: Operating Segments
Table 101. Teva: Product Portfolio
LIST OF FIGURES
Figure 01. Global Opioid Market Segmentation
Figure 02. Low-To- Moderate Bargaining Power of Supplier
Figure 03. Low Bargaining Power of Buyer
Figure 04. Moderate Threat of Substitutes
Figure 05. Low-To-Moderate Threat of New Entrants
Figure 06. High Competitive Rivalary
Figure 07. Top Player Positioning, 2018
Figure 08. Drivers And Restraints
Figure 09. Comparative Share Analysis of Opioids Market For Pain Management, By Country, 2018 & 2026 (%)
Figure 10. Global Opioids Market For Neuropathic Pain, 2018–2026 ($Million)
Figure 11. Global Opioids Market For Migraine, 2018–2026 ($Million)
Figure 12. Global Opioids Market For Back Pain, 2018–2026 ($Million)
Figure 13. Global Opioids Marker For Osteoarthritis, 2018–2026 ($Million)
Figure 14. Global Opioids Marker For Cancer Pain, 2018–2026 ($Million)
Figure 15. Global Opioids Marker For Other Apllications, 2018–2026 ($Million)
Figure 16. Comparative Share Analysis of Opioids Market For Cough Treatment, By Country, 2018 & 2026 (%)
Figure 17. Comparative Share Analysis of Opioids Market For Diarrhea Treatment, By Country, 2018 & 2026 (%)
Figure 18. Allergan: Net Sales, 2016–2018 ($Million)
Figure 19. Allergan: Revenue Share By Segment, 2018 (%)
Figure 20. Boehringer Ingelheim: Net Sales, 2016–2018 ($Million)
Figure 21. Boehringer Ingelheim: Revenue Share By Segment, 2018 (%)
Figure 22. Boehringer Ingelheim: Revenue Share By Region, 2018 (%)
Figure 23. Endo: Net Sales, 2016–2018 ($Million)
Figure 24. Endo: Revenue Share By Segment, 2018 (%)
Figure 25. J&J: Revenue, 2016–2018 ($Million)
Figure 26. J&J: Revenue Share By Segment, 2018 (%)
Figure 27. J&J: Revenue Share By Region, 2018 (%)
Figure 28. Mallinckrodt: Net Sales, 2016–2018 ($Million)
Figure 29. Mallinckrodt: Revenue Share By Segment, 2018 (%)
Figure 30. Mallinckrodt: Revenue Share By Region, 2018 (%)
Figure 31. Pfizer: Net Sales, 2016–2018 ($Million)
Figure 32. Pfizer: Revenue Share By Segment, 2018 (%)
Figure 33. Pfizer: Revenue Share By Region, 2018 (%)
Figure 34. Sanofi: Net Sales, 2016–2018 ($Million)
Figure 35. Sanofi: Revenue Share By Segment, 2018 (%)
Figure 36. Sanofi: Revenue Share By Region, 2018 (%)
Figure 37. Sun Pharma: Net Sales, 2016–2018 ($Million)
Figure 38. Sun Pharma: Revenue Share By Region, 2018 (%)
Figure 39. Teva: Net Sales, 2016–2018 ($Million)
Figure 40. Teva: Revenue Share By Segment, 2018 (%)
Figure 01. Global Opioid Market Segmentation
Figure 02. Low-To- Moderate Bargaining Power of Supplier
Figure 03. Low Bargaining Power of Buyer
Figure 04. Moderate Threat of Substitutes
Figure 05. Low-To-Moderate Threat of New Entrants
Figure 06. High Competitive Rivalary
Figure 07. Top Player Positioning, 2018
Figure 08. Drivers And Restraints
Figure 09. Comparative Share Analysis of Opioids Market For Pain Management, By Country, 2018 & 2026 (%)
Figure 10. Global Opioids Market For Neuropathic Pain, 2018–2026 ($Million)
Figure 11. Global Opioids Market For Migraine, 2018–2026 ($Million)
Figure 12. Global Opioids Market For Back Pain, 2018–2026 ($Million)
Figure 13. Global Opioids Marker For Osteoarthritis, 2018–2026 ($Million)
Figure 14. Global Opioids Marker For Cancer Pain, 2018–2026 ($Million)
Figure 15. Global Opioids Marker For Other Apllications, 2018–2026 ($Million)
Figure 16. Comparative Share Analysis of Opioids Market For Cough Treatment, By Country, 2018 & 2026 (%)
Figure 17. Comparative Share Analysis of Opioids Market For Diarrhea Treatment, By Country, 2018 & 2026 (%)
Figure 18. Allergan: Net Sales, 2016–2018 ($Million)
Figure 19. Allergan: Revenue Share By Segment, 2018 (%)
Figure 20. Boehringer Ingelheim: Net Sales, 2016–2018 ($Million)
Figure 21. Boehringer Ingelheim: Revenue Share By Segment, 2018 (%)
Figure 22. Boehringer Ingelheim: Revenue Share By Region, 2018 (%)
Figure 23. Endo: Net Sales, 2016–2018 ($Million)
Figure 24. Endo: Revenue Share By Segment, 2018 (%)
Figure 25. J&J: Revenue, 2016–2018 ($Million)
Figure 26. J&J: Revenue Share By Segment, 2018 (%)
Figure 27. J&J: Revenue Share By Region, 2018 (%)
Figure 28. Mallinckrodt: Net Sales, 2016–2018 ($Million)
Figure 29. Mallinckrodt: Revenue Share By Segment, 2018 (%)
Figure 30. Mallinckrodt: Revenue Share By Region, 2018 (%)
Figure 31. Pfizer: Net Sales, 2016–2018 ($Million)
Figure 32. Pfizer: Revenue Share By Segment, 2018 (%)
Figure 33. Pfizer: Revenue Share By Region, 2018 (%)
Figure 34. Sanofi: Net Sales, 2016–2018 ($Million)
Figure 35. Sanofi: Revenue Share By Segment, 2018 (%)
Figure 36. Sanofi: Revenue Share By Region, 2018 (%)
Figure 37. Sun Pharma: Net Sales, 2016–2018 ($Million)
Figure 38. Sun Pharma: Revenue Share By Region, 2018 (%)
Figure 39. Teva: Net Sales, 2016–2018 ($Million)
Figure 40. Teva: Revenue Share By Segment, 2018 (%)
